C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of estradiol to resemble testosterone but less one carbon at the 19 position. It is a schedule III drug in the U.S.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cyclosporine | The risk or severity of liver damage can be increased when Nandrolone phenpropionate is combined with Cyclosporine. |
| Dicoumarol | Nandrolone phenpropionate may increase the anticoagulant activities of Dicoumarol. |
| Phenindione | Nandrolone phenpropionate may increase the anticoagulant activities of Phenindione. |
| Warfarin | Nandrolone phenpropionate may increase the anticoagulant activities of Warfarin. |
| Phenprocoumon | Nandrolone phenpropionate may increase the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Nandrolone phenpropionate may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Nandrolone phenpropionate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Nandrolone phenpropionate may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Nandrolone phenpropionate may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Nandrolone phenpropionate may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Fluindione | Nandrolone phenpropionate may increase the anticoagulant activities of Fluindione. |
| Clorindione | Nandrolone phenpropionate may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Nandrolone phenpropionate may increase the anticoagulant activities of Diphenadione. |
| Tioclomarol | Nandrolone phenpropionate may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | Nandrolone phenpropionate may increase the anticoagulant activities of (S)-Warfarin. |
| Insulin human | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin human. |
| Insulin lispro | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin lispro. |
| Insulin glargine | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin glargine. |
| Insulin pork | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin pork. |
| Troglitazone | Nandrolone phenpropionate may increase the hypoglycemic activities of Troglitazone. |
| Glimepiride | Nandrolone phenpropionate may increase the hypoglycemic activities of Glimepiride. |
| Sulfisoxazole | Nandrolone phenpropionate may increase the hypoglycemic activities of Sulfisoxazole. |
| Disopyramide | Nandrolone phenpropionate may increase the hypoglycemic activities of Disopyramide. |
| Acarbose | Nandrolone phenpropionate may increase the hypoglycemic activities of Acarbose. |
| Metformin | Nandrolone phenpropionate may increase the hypoglycemic activities of Metformin. |
| Sulfadiazine | Nandrolone phenpropionate may increase the hypoglycemic activities of Sulfadiazine. |
| Rosiglitazone | Nandrolone phenpropionate may increase the hypoglycemic activities of Rosiglitazone. |
| Acetohexamide | Nandrolone phenpropionate may increase the hypoglycemic activities of Acetohexamide. |
| Quinine | Nandrolone phenpropionate may increase the hypoglycemic activities of Quinine. |
| Miglitol | Nandrolone phenpropionate may increase the hypoglycemic activities of Miglitol. |
| Chlorpropamide | Nandrolone phenpropionate may increase the hypoglycemic activities of Chlorpropamide. |
| Nateglinide | Nandrolone phenpropionate may increase the hypoglycemic activities of Nateglinide. |
| Pentamidine | Nandrolone phenpropionate may increase the hypoglycemic activities of Pentamidine. |
| Mifepristone | Nandrolone phenpropionate may increase the hypoglycemic activities of Mifepristone. |
| Tolazamide | Nandrolone phenpropionate may increase the hypoglycemic activities of Tolazamide. |
| Repaglinide | Nandrolone phenpropionate may increase the hypoglycemic activities of Repaglinide. |
| Phenformin | Nandrolone phenpropionate may increase the hypoglycemic activities of Phenformin. |
| Sulfamethoxazole | Nandrolone phenpropionate may increase the hypoglycemic activities of Sulfamethoxazole. |
| Glyburide | Nandrolone phenpropionate may increase the hypoglycemic activities of Glyburide. |
| Glipizide | Nandrolone phenpropionate may increase the hypoglycemic activities of Glipizide. |
| Gliclazide | Nandrolone phenpropionate may increase the hypoglycemic activities of Gliclazide. |
| Tolbutamide | Nandrolone phenpropionate may increase the hypoglycemic activities of Tolbutamide. |
| Pioglitazone | Nandrolone phenpropionate may increase the hypoglycemic activities of Pioglitazone. |
| Bromocriptine | Nandrolone phenpropionate may increase the hypoglycemic activities of Bromocriptine. |
| Gliquidone | Nandrolone phenpropionate may increase the hypoglycemic activities of Gliquidone. |
| Mitiglinide | Nandrolone phenpropionate may increase the hypoglycemic activities of Mitiglinide. |
| Sitagliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Sitagliptin. |
| Sunitinib | Nandrolone phenpropionate may increase the hypoglycemic activities of Sunitinib. |
| Exenatide | Nandrolone phenpropionate may increase the hypoglycemic activities of Exenatide. |
| Mecasermin | Nandrolone phenpropionate may increase the hypoglycemic activities of Mecasermin. |
| Pramlintide | Nandrolone phenpropionate may increase the hypoglycemic activities of Pramlintide. |
| Glisoxepide | Nandrolone phenpropionate may increase the hypoglycemic activities of Glisoxepide. |
| Insulin aspart | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin aspart. |
| Insulin detemir | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin detemir. |
| Insulin glulisine | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin glulisine. |
| Glymidine | Nandrolone phenpropionate may increase the hypoglycemic activities of Glymidine. |
| AICA ribonucleotide | Nandrolone phenpropionate may increase the hypoglycemic activities of AICA ribonucleotide. |
| Buformin | Nandrolone phenpropionate may increase the hypoglycemic activities of Buformin. |
| Vildagliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Vildagliptin. |
| Voglibose | Nandrolone phenpropionate may increase the hypoglycemic activities of Voglibose. |
| NN344 | Nandrolone phenpropionate may increase the hypoglycemic activities of NN344. |
| AMG-222 | Nandrolone phenpropionate may increase the hypoglycemic activities of AMG-222. |
| Bisegliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Bisegliptin. |
| Alogliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Alogliptin. |
| Dapagliflozin | Nandrolone phenpropionate may increase the hypoglycemic activities of Dapagliflozin. |
| Saxagliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Saxagliptin. |
| Liraglutide | Nandrolone phenpropionate may increase the hypoglycemic activities of Liraglutide. |
| Gosogliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Gosogliptin. |
| Linagliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Linagliptin. |
| Canagliflozin | Nandrolone phenpropionate may increase the hypoglycemic activities of Canagliflozin. |
| Glibornuride | Nandrolone phenpropionate may increase the hypoglycemic activities of Glibornuride. |
| Benfluorex | Nandrolone phenpropionate may increase the hypoglycemic activities of Benfluorex. |
| Empagliflozin | Nandrolone phenpropionate may increase the hypoglycemic activities of Empagliflozin. |
| Albiglutide | Nandrolone phenpropionate may increase the hypoglycemic activities of Albiglutide. |
| Dulaglutide | Nandrolone phenpropionate may increase the hypoglycemic activities of Dulaglutide. |
| Lobeglitazone | Nandrolone phenpropionate may increase the hypoglycemic activities of Lobeglitazone. |
| Netoglitazone | Nandrolone phenpropionate may increase the hypoglycemic activities of Netoglitazone. |
| Rivoglitazone | Nandrolone phenpropionate may increase the hypoglycemic activities of Rivoglitazone. |
| Ciglitazone | Nandrolone phenpropionate may increase the hypoglycemic activities of Ciglitazone. |
| Lixisenatide | Nandrolone phenpropionate may increase the hypoglycemic activities of Lixisenatide. |
| Insulin beef | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin beef. |
| Insulin degludec | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin degludec. |
| Insulin peglispro | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin peglispro. |
| Insulin tregopil | Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin tregopil. |
| Ipragliflozin | Nandrolone phenpropionate may increase the hypoglycemic activities of Ipragliflozin. |
| Dutogliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Dutogliptin. |
| Allicin | Nandrolone phenpropionate may increase the hypoglycemic activities of Allicin. |
| Tofogliflozin | Nandrolone phenpropionate may increase the hypoglycemic activities of Tofogliflozin. |
| Ertugliflozin | Nandrolone phenpropionate may increase the hypoglycemic activities of Ertugliflozin. |
| 2,4-thiazolidinedione | Nandrolone phenpropionate may increase the hypoglycemic activities of 2,4-thiazolidinedione. |
| Teneligliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Teneligliptin. |
| Omarigliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Omarigliptin. |
| Carmegliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Carmegliptin. |
| Gemigliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Gemigliptin. |
| Anagliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Anagliptin. |
| Evogliptin | Nandrolone phenpropionate may increase the hypoglycemic activities of Evogliptin. |
| Sotagliflozin | Nandrolone phenpropionate may increase the hypoglycemic activities of Sotagliflozin. |
| Balaglitazone | Nandrolone phenpropionate may increase the hypoglycemic activities of Balaglitazone. |
| Remogliflozin etabonate | Nandrolone phenpropionate may increase the hypoglycemic activities of Remogliflozin etabonate. |
| Carbutamide | Nandrolone phenpropionate may increase the hypoglycemic activities of Carbutamide. |